Studies related to HbA1c and Salacia reticulata

A Double Blind Randomised Placebo Controlled Cross Over Study Of A Herbal Preparation Containing Salacia Reticulata In The Treatment Of Type 2 Diabetes

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 51
Gender Both Genders
Age Range 30-44, 45-64
Body Types Average
Notes for this study:
Patients with type II diabetes given Salacia Oblonga for 3 months as a tea was associated with a decrease in HbA1c by 5.5% (overall point decrease was around 0.40%), which may have been due to preventing an increase in placebo; this underperformed relative to glibenclamide.